Asia-Pacific stocks set for mixed start; optimism rises on Pfizer vaccine approval

  • 📰 CNBC
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Pfizer and BioNTech's Covid-19 vaccine became the first in the U.S. on Monday to be granted full approval by the Food and Drug Administration.

Reuters reported that the U.S. Securities and Exchange Commission has began issuing new disclosure requirements to Chinese firms looking to list in New York.

SINGAPORE — Shares in Asia-Pacific looked set for a mixed start on Tuesday, after the tech-heavy Nasdaq Composite rose to a record closing high following theFutures pointed to a higher open in Japan. The Nikkei futures contract in Chicago was at 27,660 while its counterpart in Osaka was at 27,620. That compared against theAustralian stocks, on the other hand, looked poised for an opening slip.

 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Eyes on dua listed $BABA $JB $BIDU

good luck

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 12. in İD

Indonesia Berita Terbaru, Indonesia Berita utama